B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor

Surgery

Volumn 127, Issue 3, 2000, Pages 342-350

  Chan, Allen K ^a   Goedegebuure, Peter S ^a   Von Bernstorff, Wolfram ^a   Carritte, Amanda L ^a   Chung, Min ^a   Stewart, Robyn A ^a   Montgomery, Leslie ^a   Spanjaard, Remco A ^a   McKenzie, Allison B ^a   Eberlein, Timothy J ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ARTICLE; BREAST TUMOR; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; OVARY TUMOR; PANCREAS TUMOR; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR CELL CULTURE;

EID: 0034006444     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2000.104363     Document Type: Article

References (21)

1. 1. Goedegebuure PS, Spanjaard RA, Eberlein TJ. T cells and tumor-infiltrating lymphocytes. In: Bertino JR, editor. Encyclopedia of Cancer, Volume III San Diego: Academic Press; 1997. p. 1736-50.
2. 2. Schwartz RH. A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-56.
3. 3. June CH, Bluestone JA, Nadler LM, Thompson CB. The B7 and CD28 receptor families. Immunol Today 1994;15;321-31.
4. 4. Chen L, Linsley PS, Hellstrom KE. Costimulation of T cells for tumor immunity. Immunol Today 1993;14:483-6.
5. 5. Viola A, Lanzavecchia A. T cell activation determined by T cell receptor number and tunable thresholds. Science 1996;273:104-6.
6. 6. Townsend SE, Allison JP. Tumor rejection after direct co-stimulation of CD8+ T cells by B7-transfected melanoma cells. Science 1993;259:368-70.
7. 7. Baskar S, Ostrand-Rosenberg S, Nabavi N, Nadler LM, Freeman GJ, Glimcher LH. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Immunology 1993;90:5687-90.
8. 8. Chen L, McGowan P, Ashe S, Johnston JV, Hellstrom I, Hellstrom KE. B7-1/CD80-transduced tumor cells elicit better systemic immunity than wild-type tumor cells admixed with Corynebacterium parvum. Cancer Res 1994;54:5420-3.
9. 9. Sule-Suso J, Arienti F, Melani C, Colombo MP, Parmiani G. A B7-1-transfected human melanoma line stimulates proliferation and cytoxicity of autologous and allogeneic lymphocytes. Eur J Immunol 1995;25:2737-42.
10. 10. Schoof DD, Selleck CM, Massaro AF, Jung SF, Eberlein, TJ. Activation of human tumor-infiltrating lymphocytes by monoclonal antibodies directed to the CD3 complex. Cancer Res 1990;50:1138-43.
11. 11. Peoples GE, Schoof DD, Andrews JVR, Goedegebuure PS, Eberlein TJ. T-cell recognition of ovarian cancer. Surgery 1993;114:227-34.
12. 12. Vose BM, Bonnard GD. Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells. Nature 1982;296:359-61.
13. 13. Kalams SA, Johnson RP, Trocha AK, Dynan MJ, Ngo S, D'Aquila T, et al. Longitudinal analysis of T cell receptor (TCR) gene usage by human immunodeficiency virus 1 envelope-specific cytotoxic clones reveals a limited TCR repertoire. J Exp Med 1994;179:1261-5.
14. 14. Miescher S, Stoeck M, Qiao L, Barras C, Barrelet L, von Fliedner V. Preferential clonogenic deficit of CD8-positive T-lymphocytes infiltrating human solid tumors. Cancer Res 1998;48:6992-8.
15. 15. Iezi G, Protti MP, Rugarli C, Bellone M. B7.1 expression on tumor cells circumvents the need of professional antigen presentation for in vitro propagation of cytotoxic T cell lines. Cancer Res 1996;56:11-5.
16. 16. Townsend SE, Su FW, Atherton JM, Allison JP. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Cancer Res 1994;54:6477-83.
17. 17. Yang S, Darrow TL, Seigler HF. Generation of primary tumor-specific cytotoxic T lymphocytes from autologous and human lymphocyte antigen class I-matched allogeneic peripheral blood lymphocytes by B7 gene-modified melanoma cells. Cancer Res 1997;57:1561-8.
18. 18. Fenton RG, Turcovski-Corrales SM, Taub DD. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. J Immunother 1998;21:95-108.
19. 19. Bixby DL, Yannelli JR. CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer. Int J Cancer 1998;78:685-94.
20. 20. Peoples GE, Goedegebuure PS, Smith R, Linehan DC, Yoshino I, Eberlein TJ. Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide. Immunology 1995;92:432-6.
21. 21. Johnston JV, Malacko AR, Mizuno MT, McGowan P, Hellstrom I, Hellstron KE, et al. B7-CD28 costimulation unveils the hierarchy of tumor epitopes recognized by major histocompatibility complex class I-restricted CD8+ cytolytic T lymphocytes. J Exp Med 1996;183:791-800.